Bromine- and iodine-substituted 16alpha,17alpha-dioxolane progestins for breast tumor imaging and radiotherapy: synthesis and receptor binding affinity.
Progesterone receptors (PRs) are present in many breast tumors, and their levels are increased by certain endocrine therapies. We describe the synthesis and PR binding affinities of a series of bromine- and iodine-substituted 16alpha,17alpha-dioxolane progestins, some of which, when appropriately radiolabeled, are potential agents for diagnostic imaging of PR-positive breast tumors using positron emission tomography (PET) and for radiotherapy. These compounds were synthesized from halogenated furanyl, phenyl, and thiophenyl aldehydes and a progestin 16alpha,17alpha,21-triol (5) in the presence of HClO4 or Sc(OTf)3 in high yields under optimized conditions. A new reagent, perfluoro-1-butanesulfonyl fluoride (PBSF), was used to convert the C-21 OH to F in high yields. The relative binding affinities (RBAs) of the most promising compounds for the PR (RBA of R5020 = 100) were 16alpha,17alpha-[(R)-1'-alpha-(5-bromofurylmethylidene)dioxyl]-21-hydroxy-19-norpregn-4-ene-3,20-dione (endo-6; RBA = 65 and moderate lipophilicity), 21-fluoro-16alpha,17alpha-[(R)-1'-alpha-(5-iodofurylmethylidene)dioxyl]-19-norpregn-4-ene-3,20-dione (endo-14; RBA = 40) and 21-fluoro-16alpha,17alpha-[(S)-1'-beta-(4-iodophenylmethylidene)dioxyl]-19-norpregn-4-ene-3,20-dione (exo-16; RBA = 34).
Zhou
Dong
D
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Carlson
Kathryn E
KE
Katzenellenbogen
John A
JA
Welch
Michael J
MJ
D000818:Animals; D001667:Binding, Competitive; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy*; D004148:Dioxolanes / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D005260:Female; D009376:Neoplasms, Hormone-Dependent / Q000000981:diagnostic imaging / Q000532:radiotherapy; D009652:Norpregnenes / Q000138:chemical synthesis* / Q000737:chemistry; D011372:Progestins / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D011869:Radioligand Assay; D011877:Radionuclide Imaging; D051381:Rats; D011980:Receptors, Progesterone / Q000737:chemistry; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
C513007:16,17-(1'-alpha-(5-bromofurylmethylidene)dioxyl)-21-hydroxy-19-norpregn-4-ene-3,20-dione; C513009:21-fluoro-16,17-(1'-alpha-(4-iodofurylmethylidene)dioxyl)-21-hydroxy-19-norpregn-4-ene-3,20-dione; C513008:21-fluoro-16,17-(1'-alpha-(5-iodofurylmethylidene)dioxyl)-19-norpregn-4-ene-3,20-dione; D004148:Dioxolanes; D009652:Norpregnenes; D011372:Progestins; D011980:Receptors, Progesterone; C097314:progesterone receptor B